Presumed Candida endogenous fungal endophthalmitis: a case report and literature review
- PMID: 17765856
- DOI: 10.1016/j.optm.2007.02.020
Presumed Candida endogenous fungal endophthalmitis: a case report and literature review
Abstract
Background: Endogenous fungal endophthalmitis (EFE) is a rare intraocular infection that has recently increased in incidence over the last few decades. The most common causative organism of endogenous endophthalmitis is Candida albicans. Treatment generally is initiated with an antifungal drug systemically and, depending on the ocular findings, may also include a vitrectomy with the injection of an intraocular antifungal agent. Specific predisposing factors may make a patient more at risk for development of an ocular infection.
Case report: We present a case of presumed Candida endogenous endophthalmitis in an 83-year-old white man with a Candida albicans urinary tract infection and describe the general characteristics, treatment, and management of this condition.
Conclusion: Endogenous fungal endophthalmitis is a potentially blinding condition that can signal an underlying systemic infection. Without a dilated fundus examination in the presence of ocular inflammation, the condition easily can be misdiagnosed. Fungal infection may lead to retinal and vitreal lesions that can be visually debilitating if left untreated. Prognosis for visual outcome is dependent on timely diagnosis and initiation of treatment.
Similar articles
-
Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.Ophthalmic Surg Lasers. 1997 Mar;28(3):185-94. Ophthalmic Surg Lasers. 1997. PMID: 9076791
-
Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.Ophthalmic Surg Lasers. 1996 Dec;27(12):1012-8. Ophthalmic Surg Lasers. 1996. PMID: 8976520
-
Treatment of presumed fungal endophthalmitis with oral fluconazole.Ophthalmic Surg Lasers. 1996 Jul;27(7):628-31. Ophthalmic Surg Lasers. 1996. PMID: 9240781
-
Candida endophthalmitis: focus on current and future antifungal treatment options.Pharmacotherapy. 2007 Dec;27(12):1711-21. doi: 10.1592/phco.27.12.1711. Pharmacotherapy. 2007. PMID: 18041891 Review.
-
Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.Infection. 2006 Oct;34(5):285-8. doi: 10.1007/s15010-006-5119-3. Infection. 2006. PMID: 17033755 Review.
Cited by
-
Confirmed Candida albicans endogenous fungal endophthalmitis in a patient with chronic candidiasis.Med Mycol Case Rep. 2012 Jun 16;1(1):42-4. doi: 10.1016/j.mmcr.2012.06.001. eCollection 2012. Med Mycol Case Rep. 2012. PMID: 24371735 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical